Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...
On this edition of “Lessons in Leadership”, Steve Adubato and Mary Gamba talk with Delaney McGowan, Senior Producer, ...
Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback